A biotech company, Naurex, is gathering data that suggests it may have a drug that works faster and better than anything on the market, reports Luke Timmerman of Forbes.

The novel drug targets the NMDA receptor. Researchers included Susan McElroy, MD, Professor of Psychiatry and Behavioral Neuroscience at UC and a member of the UC Mood Disorders Center.

Media outlet: Forbes
Read the story >